|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
CHI's Fourth Annual HUMAN GENETIC VARIATION | ||||||||||||||||
September 21, 2001 | ||||||||||||||||
Cambridge Healthtech Institute, Cambridge Marriott, Cambridge, Massachusetts New dates: October 9-10, 2001 CHI's Fourth Annual HUMAN GENETIC VARIATION The race is on to secure worthwhile information from the published human genome. As the emphasis shifts from de novo sequencing to understanding differences in individuals, a variety of approaches will be used to most quickly unlock the value of genomics. While there are many finishing lines across wide-ranging boundaries, to claim the prize it is still imperative to get there first. This meeting will provide a focal point to accelerate your knowledge base and propel your programs forward. That there are fewer genes than supposed has ironically increased complexity rather than reduced it. More than ever, technological feats must be united with clinical significance. This area of study has evolved into a science that impacts daily lives, and it is well to remember R.A. Fisher's fundamental theorem of natural selection, "The rate of increase in fitness of any organism at any time is equal to its genetic variance in fitness at that time." So come to Boston for a mental workout and get fit for the race. |
||||||||||||||||
Organized by: | Cambridge Healthtech Institute | |||||||||||||||
Invited Speakers: | Session Chairs Dr. Mike Makrigiorgos, Dana-Farber Cancer Institute and Harvard Medical School Dr. Nick Short, Iceland Genomics Corporation Dr. Karen Thomas. Incyte Genomics, Inc. Additional Speakers Dr Stacey (Bolk) Gabriel, The Whitehead Institute Center for Genome Research Dr. Philippe Douville, Galileo Genomics Dr. Michael Heller, Nanogen, Inc. Dr. Merl F. Hoekstra, Epoch Biosciences, Inc. Dr. Kristina Lejon, UmanGenomics AB Dr. Anu Loukola Aeomica Inc/Amersham Pharmacia Biotech Dr. Andres Metspalu, Estonian Genome Project Mr. Kelley Murphy, Peoples Genetics, Inc. Dr. Les Sheffield, Royal Children's Hospital Dr. Emil Skamene, McGill University Health Centre Dr. Scott Stanley, Genaissance Pharmaceuticals, Inc. Dr. Kari Stefansson, deCODE genetics Dr. Rick Woychik, LYNX Therapeutics Dr. Hannah Hong Xue, PharmacoGenetics Limited |
|||||||||||||||
Deadline for Abstracts: | August 10, 2001 | |||||||||||||||
Registration: | http://www.chidb.com/2001/gvr/gvr_form.htm | |||||||||||||||
E-mail: | fvargus@healthtech.com | |||||||||||||||
Posted by: | Frederick Vargus | |||||||||||||||
Host: | wks253.healthtech.com | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |